How body fat speeds up aging in men: The science of metabolism and longevity

In men, excess visceral (deep belly) fat speeds up aging by acting as an inflammatory endocrine organ that releases cytokines such as TNF-α and IL-6, driving chronic inflammation, insulin resistance, and faster atherosclerosis. Losing just 5 to 10% of body weight in midlife can measurably improve blood sugar, blood pressure, and inflammatory markers. This makes fat loss one of the most reliable levers for longevity.

Key takeaways

• Excess visceral (deep belly) fat in men can speed up biological aging by driving chronic inflammation, insulin resistance, and faster atherosclerosis, even when BMI is only mildly elevated.
• Visceral fat acts like an endocrine organ that releases inflammatory cytokines such as TNF-α and IL-6, sending signals that damage blood vessels and impair insulin action throughout the body.
• Losing just 5 to 10% of body weight in midlife can measurably improve blood sugar, blood pressure, and inflammatory markers, making fat loss one of the most reliable longevity levers for men.
• A waist circumference over about 40 inches (102 cm) is a practical red flag for high visceral fat, and common lab clues include fasting glucose above 100 mg/dL and triglycerides above 150 mg/dL.
• Male hypogonadism requires persistent symptoms plus low morning testosterone on repeat testing, with LH and FSH measured to identify the cause. A sustainable fat-loss plan typically pairs a 300 to 500 calorie per day deficit with high protein (about 0.8 to 1.0 g per lb of goal body weight), resistance training 2 to 4 days per week, and 7 to 9 hours of quality sleep.

The relationship

Excess visceral fat accelerates biological aging in men by increasing inflammation, insulin resistance, and cardiovascular risk. Fat tissue is not inert storage. It releases hormones and immune signals that act on the brain, blood vessels, liver, muscle, and testes.

Adipose tissue is the medical term for body fat, including the fat under the skin and the deeper fat around the organs. Visceral fat is the deep belly fat packed around the liver, intestines, and pancreas. Men commonly store fat in this visceral pattern.

A 2008 New England Journal of Medicine study of 359,387 adults in nine European countries found that, after adjustment for BMI, men in the highest fifth of waist circumference had about twice the risk of death over a mean 9.7 years (relative risk 2.05).^[1] The authors concluded that waist circumference adds to BMI in assessing the risk of death, which is one reason waist size matters alongside BMI for longevity risk in men.^[1] A 2006 New England Journal of Medicine analysis of 527,265 U.S. adults aged 50 to 71 found that, among people who had never smoked, being overweight at age 50 was associated with a 20 to 40% higher risk of death and obesity with two to three times the risk or more.^[2]

Weight loss improves many of the markers that sit on this pathway. In the Look AHEAD trial, 5,145 overweight or obese adults with type 2 diabetes were assigned to an intensive lifestyle program or to diabetes education.^[3] The lifestyle group lost 8.6% of body weight at one year, compared with 0.7%, and had greater improvements in glycated hemoglobin, fitness, and every cardiovascular risk factor measured except LDL cholesterol. The program did not reduce the combined rate of cardiovascular death, heart attack, stroke, and hospitalization for angina over a median 9.6 years, so better risk markers do not automatically translate into fewer cardiovascular events.^[3]

How it works

Visceral fat changes the hormonal and immune signals the body runs on, and the effects build over years. In men with central obesity, the same drivers tend to appear together: inflammation, insulin resistance, higher triglycerides, fatty liver changes, and, in many men, lower testosterone. That shared origin is why reducing waist size can improve several lab markers at once.

Visceral fat and chronic inflammation

Chronic inflammation is long-term, low-grade activation of the immune system that slowly damages tissues. According to a 2011 review in Nature Reviews Immunology, obesity causes this kind of chronic low-grade inflammation: fat tissue works as an endocrine organ, and when it becomes dysfunctional it releases more pro-inflammatory signaling proteins, including tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6).^[4]

The same review describes how these signals contribute to the metabolic dysfunction behind obesity-linked disorders, including impaired insulin action and atherosclerosis, the plaque-building process in arteries.^[4] Insulin is the hormone that moves sugar from the blood into cells. Over time, this combination is associated with a higher risk of type 2 diabetes, heart attack, and stroke.

Hormones, testosterone, and aromatase

Leptin is a hormone made by fat cells that signals fullness to the brain. Adiponectin is a hormone from fat that improves insulin sensitivity, or how well cells respond to insulin. With excess body fat, leptin levels are typically high while adiponectin is low, a pattern linked to insulin resistance and poorer metabolic control.^[4]

Fat tissue also contains aromatase, an enzyme that converts testosterone into estradiol, a form of estrogen that is present in small but important amounts in men. As body fat increases, aromatase activity rises and testosterone levels in men with obesity often fall, while estradiol levels rise.

According to the 2018 Endocrine Society clinical practice guideline, hypogonadism should be diagnosed only in men with symptoms and signs of testosterone deficiency and unequivocally, consistently low testosterone, using a fasting morning total testosterone measured with an accurate assay and confirmed by a repeat test.^[5] When total testosterone is near the lower limit of normal, or when a condition alters sex hormone binding globulin (SHBG), the protein that carries testosterone in the blood, the guideline recommends measuring free testosterone by equilibrium dialysis or estimating it with an accurate formula.^[5] Obesity is one such condition, because it lowers SHBG. A study that harmonized testosterone measurements across four U.S. and European cohorts placed the lower limit of the normal range (the 2.5th percentile) for healthy nonobese men aged 19 to 39 at 264 ng/dL.^[6]

Lower testosterone in men with obesity is associated with reduced muscle mass, further fat gain, lower libido, and erectile problems, which can make losing fat harder.

Insulin resistance and metabolic slowdown

Insulin resistance means cells respond poorly to insulin, so the pancreas has to release more of it to keep blood sugar in range. A 1988 review in Diabetes, published from the Banting lecture, described how this compensatory high-insulin state keeps blood sugar under control only as long as the pancreas can sustain it.^[7] When it cannot, fasting blood sugar rises. The review also noted that people with high blood pressure, treated or untreated, tend to be insulin resistant with high insulin levels.^[7]

Visceral fat drains into the portal vein, the blood vessel that carries blood to the liver, so the liver is directly exposed to what that fat releases. In insulin resistance, insulin no longer suppresses free fatty acids in the blood normally, and higher free fatty acid levels push the liver to produce more glucose, which worsens fasting blood sugar.^[7] For many men, this is the point at which a growing waistline becomes full metabolic syndrome, a cluster of high blood pressure, high blood sugar, high triglycerides, low HDL cholesterol, and a large waist that raises cardiovascular risk.

Mitochondria, muscle, and energy use

Mitochondria are the structures inside cells that turn food into usable energy. Insulin-resistant muscle often shows reduced mitochondrial function, although whether this is a cause or a consequence of insulin resistance is still debated.

Sarcopenia is the age-related loss of muscle mass and strength. Men with higher body fat and lower testosterone tend to lose muscle faster, sometimes with little change on the scale, because fat replaces muscle. Less muscle means a lower resting metabolic rate, less strength and power, slower reaction times, and a higher risk of falls and fractures later in life.

Conditions linked to it

Excess fat in men is linked to many age-related conditions. They often cluster because visceral fat raises inflammatory signaling and insulin resistance, which in turn worsen blood pressure, blood lipids, liver fat, and blood vessel function. Small shifts in several systems can add up to a higher risk profile than any single number on a lab report suggests.

• Type 2 diabetes: Insulin resistance is present in most people with impaired glucose tolerance or type 2 diabetes.^[7] In the Diabetes Prevention Program, adults with elevated blood sugar who joined a lifestyle program aiming for at least 7% weight loss and 150 minutes of weekly physical activity developed type 2 diabetes 58% less often than those given placebo.^[8]
• Cardiovascular disease: Belly fat is associated with high blood pressure, abnormal cholesterol, and coronary artery disease in men. In the INTERHEART study of about 27,000 people in 52 countries, waist-to-hip ratio had a graded, strong association with heart attack risk, while the association with BMI was modest and was substantially weakened once waist-to-hip ratio was taken into account.^[9]
• Low testosterone and sexual dysfunction: Men with obesity are more likely to have low total and free testosterone, erectile dysfunction, and reduced sexual desire, which can further reduce physical activity and muscle building. Per Endocrine Society guidance, the diagnosis requires symptoms plus consistently low morning testosterone on repeat testing.^[5]
• Nonalcoholic fatty liver disease (NAFLD): Fat accumulation in the liver is common in men with central obesity and insulin resistance and can progress to liver inflammation and scarring over time.
• Sleep apnea: Neck and visceral fat narrow the upper airway in men, raising the risk of obstructive sleep apnea, which fragments sleep, raises blood pressure, and worsens insulin resistance.
• Cognitive decline: In the Baltimore Longitudinal Study of Aging, which followed 2,322 participants for a median 23.4 years, men whose BMI rose the most between ages 30 and 50 had about 3.7 times the risk of Alzheimer’s disease, and men who were underweight in early adulthood were also at higher risk. The study was observational and recorded 187 cases, so the estimates are imprecise.^[10]

If several issues emerge at once, such as higher blood pressure, rising glucose, and worsening sleep, it is worth involving a clinician. Treating sleep apnea, prediabetes, hypertension, and abnormal cholesterol early can reduce long-term cardiovascular risk.

Not every man with extra fat will develop all of these conditions. Some men remain “metabolically healthy” despite higher weight, at least for a time, but long-term follow-up suggests their risk usually rises with the years, especially when visceral fat is high.

Symptoms and signals

Many early signs that body fat is starting to affect metabolism are visible or felt in daily life. They are not specific to fat: stress, short sleep, medication side effects, depression, and thyroid or testosterone problems can look similar. When several signs appear together, it is worth checking objective measures such as waist circumference, blood pressure, and basic labs.

• Growing waistline: Pants tightening around the midsection, or a waist over about 40 inches (102 cm) in most men, suggests rising visceral fat.
• Slower energy and recovery: Feeling wiped out after normal workouts, taking longer to recover from minor injuries, or needing more caffeine to get going.
• Low drive and libido: Reduced interest in sex, weaker morning erections, or difficulty maintaining erections, especially when combined with weight gain.
• Snoring and poor sleep: Loud snoring, gasping at night, or waking unrefreshed despite enough sleep can point to sleep apnea driven by extra fat around the neck and airway.
• Blood pressure creeping up: Readings that used to be in the 120s now sitting in the 130s or 140s, even without a change in routine.
• Lab clues: Fasting blood sugar above 100 mg/dL, triglycerides above 150 mg/dL, low HDL (good) cholesterol, or mildly elevated liver enzymes on routine blood work.
• Shape change without major scale change: Same weight as a decade ago, but softer, with less visible muscle and more padding around the middle.

Seek clinician evaluation sooner if you have chest pain, new shortness of breath with exertion, very high blood pressure, signs of sleep apnea such as witnessed pauses in breathing, or persistent sexual dysfunction. These problems are often treatable, but they can also signal cardiovascular risk that should not be ignored.

What to do about it

Because body fat drives so much of this risk, reducing it can change the trajectory. A plan that improves waist size, strength, sleep, and cardiometabolic labs together is more likely to last than an aggressive short-term diet that rebounds.

Step 1: Get a clear baseline

Start with simple numbers that track visceral fat and metabolic health:

• Measure waist circumference at the level of the belly button. For most men, a waist over 40 inches signals high visceral fat.
• Ask your clinician for fasting blood work: glucose, HbA1c (3-month average blood sugar), lipid panel, CBC, CMP, total testosterone, free testosterone by equilibrium dialysis with LC-MS/MS, LH, FSH, estradiol, and PSA if you are 40 or older.
• If you have symptoms such as low libido, erectile dysfunction, infertility concerns, or persistent fatigue, discuss repeat morning hormone testing between 7:00 and 11:00 a.m. to confirm a low result.^[5] Free testosterone matters more than usual in men with excess weight, because obesity lowers SHBG. LH and FSH show whether the problem starts in the testes or in the pituitary and hypothalamus.
• Screen for sleep apnea if you snore loudly, stop breathing at night, or wake unrefreshed.

Step 2: Work on food, training, sleep, and, when needed, medicine

For most men, fat loss that supports longevity does not require extreme diets or two-a-day workouts. It requires consistent effort on the habits that control metabolism.

• Nutrition for fat loss and hormone health: Aim for a modest calorie deficit of about 300 to 500 calories per day, with higher protein intake (around 0.8 to 1.0 grams per pound of goal body weight) to preserve muscle. Base most meals on lean protein, high-fiber vegetables, whole grains or starchy vegetables, and healthy fats. Limit ultra-processed foods, sugary drinks, and frequent late-night eating, which worsen insulin resistance and visceral fat storage.
• Resistance and aerobic training: Resistance training 2 to 4 days per week helps build and maintain muscle, supports resting metabolism, and improves insulin sensitivity in men of all ages. Add brisk walking, cycling, or other aerobic work most days to burn calories and improve heart and brain blood flow.
• Sleep and stress: Poor sleep raises hunger hormones and lowers insulin sensitivity. Treating sleep apnea and aiming for 7 to 9 hours of quality sleep can make fat loss easier and support testosterone production. Daily walking, breathing exercises, or short mindfulness practices can also blunt the stress-hormone spikes that drive emotional eating.
• Medications and procedures when appropriate: In men with obesity, GLP-1 receptor agonists can produce substantial weight loss. In the STEP 1 trial, 1,961 adults with overweight or obesity and without diabetes lost an average 14.9% of body weight over 68 weeks on weekly semaglutide plus a lifestyle program, compared with 2.4% on placebo.^[11] SGLT2 inhibitors generally produce modest weight loss but can improve glycemic control and cardiovascular and kidney outcomes in appropriate patients. In the STAMPEDE trial of 150 adults with type 2 diabetes, five years after surgery body weight was 23% lower after gastric bypass and 19% lower after sleeve gastrectomy, compared with 5% lower with intensive medical therapy alone, and 29% and 23% of surgical patients reached a glycated hemoglobin of 6.0% or less, compared with 5% of the medical group.^[12]
• Treating confirmed low testosterone: The Endocrine Society recommends against starting testosterone therapy in men who plan to father a child in the near term.^[5] Testosterone therapy suppresses LH and FSH and, with them, sperm production. It is the standard treatment for primary hypogonadism, where the testes themselves fail. In secondary or functional hypogonadism, where the testes are intact, weight loss can raise testosterone, and fertility-preserving options such as enclomiphene raise the body’s own LH and testosterone.

Veedma offers testing that includes total and free testosterone measured by LC-MS/MS with LH and FSH, or a review of labs you already have, interpreted by licensed providers. When appropriate, treatment is enclomiphene or the enclomiphene plus tadalafil tablet; Veedma’s protocol uses free testosterone below 100 pg/mL with persistent symptoms as its treatment threshold. Enclomiphene is not an FDA-approved drug; it is prescribed after a provider confirms the diagnosis and is compounded by a licensed U.S. pharmacy.

Myth vs fact

Myth: Fat gain is an unavoidable part of male aging.

Fact: Metabolism does slow slightly with age, but men who stay active, lift weights, and manage food quality can maintain healthy body fat and muscle well into their 60s and 70s.

Myth: You can out-train a bad diet.

Fact: Exercise is vital for muscle, brain, and heart, but most men cannot outrun consistent overeating. Nutrition drives fat loss; training protects muscle and adds its own benefits.

Myth: All body fat is equally bad.

Fact: Subcutaneous fat, the fat under the skin, is less harmful than visceral fat around the organs. In a large European cohort, a larger waist was linked to a higher risk of death even after accounting for BMI.^[1]

Myth: Carbs always wreck metabolism and testosterone in men.

Fact: Very low-carb diets work for some men, but many do well with moderate carbs from whole foods. Total calories, protein, and training habits matter more than carb avoidance for testosterone and metabolic health.

Myth: Quick crash diets are a good way to reset metabolism.

Fact: Aggressive crash diets strip muscle along with fat and can lower resting metabolism. Slower, sustainable fat loss plus strength training is better for long-term health and aging.

Bottom line

Excess visceral fat behaves like an active organ. It promotes chronic inflammation, lowers testosterone, and raises the risk of type 2 diabetes, heart disease, and earlier death in men.

The steps that reduce waist size, namely better eating, consistent strength and aerobic training, enough sleep, and medical treatment when needed, also help men stay stronger, sharper, and more independent for more years.

References

1. Pischon T, Boeing H, Hoffmann K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med. 2008;359:2105-20. PMID: 19005195
2. Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006;355:763-78. PMID: 16926275
3. Look AHEAD Research Group, Wing RR, Bolin P, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369:145-54. PMID: 23796131
4. Ouchi N, Parker JL, Lugus JJ, et al. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11:85-97. PMID: 21252989
5. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103:1715-1744. PMID: 29562364
6. Travison TG, Vesper HW, Orwoll E, et al. Harmonized Reference Ranges for Circulating Testosterone Levels in Men of Four Cohort Studies in the United States and Europe. J Clin Endocrinol Metab. 2017;102:1161-1173. PMID: 28324103
7. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-607. PMID: 3056758
8. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403. PMID: 11832527
9. Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366:1640-9. PMID: 16271645
10. Beydoun MA, Lhotsky A, Wang Y, et al. Association of adiposity status and changes in early to mid-adulthood with incidence of Alzheimer’s disease. Am J Epidemiol. 2008;168:1179-89. PMID: 18835864
11. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384:989-1002. PMID: 33567185
12. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric Surgery versus Intensive Medical Therapy for Diabetes – 5-Year Outcomes. N Engl J Med. 2017;376:641-651. PMID: 28199805